Meeting
2011 ASCO Annual Meeting
Adjuvant hormone therapy use in early-stage breast cancer patients insured by the New York State Medicaid program.
Authors
R. L. Yung
Dana-Farber Cancer Institute, Boston, MA
R. L. Yung , M. J. Hassett , K. Chen , F. C. Gesten , P. R. Roohan , F. P. Boscoe , A. H. Sinclair , M. J. Schymura , D. Schrag
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Health Services Research
Track
Health Services Research
Sub Track
Health Services Research
Citation
J Clin Oncol 29: 2011 (suppl; abstr 6031)
Abstract #
6031
Poster Bd #
20
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Influence of ovarian function supression on quality of life in breast cancer survivors during adjuvant endocrine therapy.
First Author: Natalija Dedic Plavetic
Poster
2013 ASCO Annual Meeting
Racial disparities in initiation of endocrine therapy for early-stage breast cancer.
First Author: Katherine Elizabeth Reeder-Hayes
Poster
2012 Breast Cancer Symposium
Vascular toxicities of endocrine therapy in early-stage breast cancer: Encouraging observations in a nontrial setting.
First Author: Susan Dent
Poster
2011 ASCO Annual Meeting
Symptom experiences and nonadherent medication-taking behaviors of breast cancer patients taking adjuvant hormone therapy.
First Author: R. A. Shelby